Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals

Recently, two oral-administered peptide pharmaceuticals, semaglutide and octreotide, have been developed and are considered as a breakthrough in peptide and protein drug delivery system development. In 2019, the Food and Drug Administration (FDA) approved an oral dosage form of semaglutide developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jae Cheon, Park, Eun Ji, Na, Dong Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781085/
https://www.ncbi.nlm.nih.gov/pubmed/36559036
http://dx.doi.org/10.3390/ph15121585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781085/
https://www.ncbi.nlm.nih.gov/pubmed/36559036
http://dx.doi.org/10.3390/ph15121585

Ejemplares similares